Libivirumab (17.1.41) is a human monoclonal antibody targeting the hepatitis B virus (HBV). It exhibits potent neutralizing activity against HBV surface antigen (HBsAg) and HBV e antigen (HBeAg), with half-maximal inhibitory concentrations (IC50) of 35 ng/mL and 130 ng/mL, respectively. This antibody is designed for use in research studies aimed at understanding HBV pathogenesis and for the development of therapeutic strategies against HBV infections.
Libivirumab (17.1.41) is a human monoclonal antibody targeting the hepatitis B virus (HBV). It exhibits potent neutralizing activity against HBV surface antigen (HBsAg) and HBV e antigen (HBeAg), with half-maximal inhibitory concentrations (IC50) of 35 ng/mL and 130 ng/mL, respectively. This antibody is designed for use in research studies aimed at understanding HBV pathogenesis and for the development of therapeutic strategies against HBV infections.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
